3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Parkinson Disease 4, Autosomal Dominant Lewy Body
8
Carcinoma, Non-Small-Cell Lung
8
Melanoma
7
Squamous Cell Carcinoma of Head and Neck
6
Ovarian Neoplasms
6
Lung Neoplasms
6
Head and Neck Neoplasms
5
Carcinoma, Transitional Cell
4
Stomach Neoplasms
3
Lymphoma
3
Colorectal Neoplasms
3
Carcinoma, Renal Cell
3
Triple Negative Breast Neoplasms
2
Small Cell Lung Carcinoma
2
Neoplasm Metastasis
2
Glioblastoma
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Hepatocellular
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thymus Neoplasms
1
Thymoma
1
Sarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Myelodysplastic Syndromes
1
Microsatellite Instability
1
Interventions
Cisplatin
4
pembrolizumab
3
Nivolumab
3
Fluorouracil
2
Carboplatin
2
toripalimab
1
spartalizumab
1
fludarabine phosphate
1
fludarabine
1
cc-486
1
camrelizumab
1
Vorinostat
1
Valganciclovir
1
Range of Motion, Articular
1
Radiotherapy
1
Radiosurgery
1
Protons
1
Platinum
1
Methylprednisolone
1
Medicare Part B
1
Laryngoscopes
1
Gemcitabine
1
Docetaxel
1
Cyclophosphamide
1
Cetuximab
1
Bevacizumab
1
Azacitidine
1
Adrenal Cortex Hormones
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Nasopharyngeal Carcinoma
×
epacadostat
×
Clear all
No trials found.